| Abstrakt: |
This article explores the concept of decentralized clinical trials (DCTs) and their potential benefits in research. DCTs involve conducting study-related activities at locations separate from the investigator's location, with a focus on participant-centered approaches. These trials can be fully remote or partially decentralized, depending on the trial's needs. DCTs have the potential to improve trial access, inclusivity, and data collection. However, it is important to consider factors such as the condition under study and the trial population when deciding if decentralized methods are suitable. The article also emphasizes the importance of site readiness in terms of the research team's skills, training, and access to technology. It addresses challenges related to data collection, ethics, and safety, and suggests that site readiness practices can help overcome these challenges and improve the selection of appropriate sites for decentralized trials. [Extracted from the article] |
